摘要
目的探讨持续质量改进对辅助用药注射剂使用情况的影响。方法调取2018年1-12月中山大学附属第五医院内分泌科4 256例患者辅助用药注射剂相关数据,对1-6月(持续质量改进前)2 120例及7-12月(持续质量改进后)2136例患者辅助用药注射剂使用情况进行分析与比较。结果干预后患者辅助用药金额及人均辅助用药费用均低于干预前,差异有统计学意义(P<0.05);干预后辅助用药注射剂三联及三联以上用药患者比例均低于干预前,差异有统计学意义(P<0.05);干预后辅助用药注射剂使用不合理处方数明显少于干预前,同时患者不良反应发生率低于干预前,差异有统计学意义(P<0.05)。结论将持续质量改进用于辅助用药注射剂使用管理中,可有效减少辅助用药金额及药物使用不合理现象,同时降低三联及以上药物使用率,从而促进药物合理使用。
Objective To explore the effects of continuous quality improvement on the use of auxiliary drug injections in our hospital. Methods A total of 4256 patients with adjuvant injections in the Department of Endocrinology, Fifth Affiliated Hospital of Sun Yat-sen University from January to December 2018 were selected. The use of auxiliary injections in 2120 patients(before continuous quality improvement) in the first half of the year and 2136 patients(after continuous quality improvement) in the second half of the year were analyzed and compared. Results After intervention, the amount of supplementary drug use and the cost of per capita supplementary drug use were lower than those before intervention(P<0.05);After intervention, the proportion of patients with triple or more drug injections was lower than that before intervention.(P<0.05). The number of unreasonable prescriptions for adjuvant drug injections after intervention was significantly less than that before intervention, and the incidence of adverse reactions was lower than that before intervention(P<0.05). Conclusion The use of continuous quality improvement in the management of the use of auxiliary drug injections effectively reduce the amount of auxiliary drugs and unreasonable drug use, and reduce the use rate of triple or more drugs and the above, so as to promote the rational use of drugs.
作者
叶伟斌
吕台中
徐辉
YE Wei-Bin;LV Tai-Zhong;XU Hui(Department of Pharmacy,Fifth Hospital Affiliated to Sun Yat-sen University,Zhuhai 519000,China)
出处
《中国药物经济学》
2019年第11期123-125,共3页
China Journal of Pharmaceutical Economics
关键词
辅助用药注射剂
持续质量改进
使用情况
Auxiliary drug injection
Continuous quality improvement
Usage
